Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019

SELL
$39.4 - $42.7 $341,598 - $370,209
-8,670 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$39.75 - $42.69 $46,110 - $49,520
-1,160 Reduced 11.8%
8,670 $348,000
Q1 2018

May 04, 2018

BUY
$36.18 - $40.15 $355,649 - $394,674
9,830 New
9,830 $384,000
Q4 2017

Feb 02, 2018

SELL
$35.34 - $41.9 $347,038 - $411,458
-9,820 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$39.44 - $41.55 $387,300 - $408,021
9,820
9,820 $399,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Opus Capital Group, LLC Portfolio

Follow Opus Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.